---
title: Pfizer’s Begins Clinical Trials for Antiviral
description: Pfizer’s Begins Clinical Trials for Antiviral
---

[News ](https://www.yourway.com/news)

# [Pfizer’s Begins Clinical Trials for Antiviral](https://www.yourway.com/news/pfizers-begins-clinical-trials-for-antiviral)

 Written by [Yourway](https://www.yourway.com/news/author/yourway) | September 22, 2020

Pfizer has [initiated ](https://cen.acs.org/pharmaceuticals/drug-discovery/Pfizers-novel-COVID-19-antiviral/98/web/2020/09)Phase 1 clinical tests of PF-07304814, a small molecule that could be used in the fight against SARS-CoV-2, which causes COVID-19. The drug targets the 3CL protease, an enzyme that allows the virus to multiply. If approved, PF-07304814 would be the first antiviral drug to target this protein. With 21 strategically located global depots, Yourway can fully support global trial needs around the world.

[View full post](https://www.yourway.com/news/pfizers-begins-clinical-trials-for-antiviral)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Yourway"
  },
  "dateModified" : "2020-09-22T09:15:00.497Z",
  "datePublished" : "2020-09-22T09:15:00Z",
  "headline" : "Pfizer’s Begins Clinical Trials for Antiviral",
  "image" : {
    "@type" : "ImageObject",
    "height" : 685,
    "url" : "https://f.hubspotusercontent30.net/hubfs/5402331/News%20and%20Articles%20Banners/YRWY_News_083120.jpg",
    "width" : 1440
  },
  "mainEntityOfPage" : "https://www.yourway.com/news/pfizers-begins-clinical-trials-for-antiviral",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News"
  }
}
```